2000
DOI: 10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n
|View full text |Cite
|
Sign up to set email alerts
|

Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

Abstract: Consistent gene mutation nomenclature is essential for efficient and accurate reporting, testing, and curation of the growing number of disease mutations and useful polymorphisms being discovered in the human genome. While a codified mutation nomenclature system for simple DNA lesions has now been adopted broadly by the medical genetics community, it is inherently difficult to represent complex mutations in a unified manner. In this article, suggestions are presented for reporting just such complex mutations. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
715
0
10

Year Published

2002
2002
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,615 publications
(746 citation statements)
references
References 4 publications
6
715
0
10
Order By: Relevance
“…Differences in nomenclature between ExAC and our internal variant database were reconciled with the HGVS-approved standard for each variant in the data set to ensure accuracy of ascertainment. 6 To derive traceable comparisons for each gene, the evidence supporting phenotype prevalence, locus/allelic heterogeneity, and penetrance was used to estimate the maximal pathogenic allele frequency (MPAF) for each gene (Supplementary Table S1 online). MPAF provides a conservative maximum expected frequency of pathogenic alleles in any gene under the assumption that the corresponding disease is entirely attributable to a single pathogenic variant.…”
Section: Data Collection and Analysismentioning
confidence: 99%
“…Differences in nomenclature between ExAC and our internal variant database were reconciled with the HGVS-approved standard for each variant in the data set to ensure accuracy of ascertainment. 6 To derive traceable comparisons for each gene, the evidence supporting phenotype prevalence, locus/allelic heterogeneity, and penetrance was used to estimate the maximal pathogenic allele frequency (MPAF) for each gene (Supplementary Table S1 online). MPAF provides a conservative maximum expected frequency of pathogenic alleles in any gene under the assumption that the corresponding disease is entirely attributable to a single pathogenic variant.…”
Section: Data Collection and Analysismentioning
confidence: 99%
“…30 When the nucleotide position is indicated, the GenBank cDNA reference sequences were used as follows: AIPL1 (NG_008474.1); CEP290 (NG_008417.1); CRB1 (NG_008483.1); GUCY2D (NG_009092.1); LRAT (NG_009110.1); RDH12 (NG_008321.1); RPE65 (NG_008472.1); RPGRIP1 (NG_008933.1); and TULP1 (NG_009077.1). 31 …”
Section: Sequence Variants Nomenclaturementioning
confidence: 99%
“…The descriptions of the mutations were conformed, if necessary, based on ''Guidelines for mutation nomenclature'' from Human Genome Variation Society. 18 1 V600E in main tumors, and V600_K601delinsE in metastatic lymph nodes (three classic cases). 2 G474R mutant has impaired kinase activity and could be a passenger mutation.…”
Section: A Novel Braf Mutation Detected In Ptcmentioning
confidence: 99%